Shares of USANA Health Sciences Inc. (USNA) slipped 3% in extended session on Thursday after the company lowered its financial outlook for fiscal year 2021.
The company now expects full year 2021 earnings of $5.80 to $6.00 per share and revenues of $1.18 billion to $1.20 billion. Previously, the company expected earnings of $6.15 to $6.50 per share on revenues of $1.24 to $1.28 billion.
The company currently anticipates third quarter sales of $265 million to $270 million and earnings of $1.28 and $1.33 per share.
"Our sales results for the third quarter have been softer than we anticipated, largely because of increased disruptions and lockdowns in several of our markets due to the escalation of the COVID-19 pandemic," said Kevin Guest, Chief Executive Officer and Chairman of the Board.
USNA closed Thursday's trading at $87.46, down $0.05 or 0.06%, on the Nasdaq. The stock further slipped $2.69 or 3.08% in the after-hours trade.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.